Seasonal Vaccine Manufacturing

The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022.  It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizations (CMOs) to support.

There are three areas to be evaluated when vaccine developers are evaluating external drug product manufacturing partners: 

  • Right facility and technical capabilities
  • Culture of speed and execution / Shared Expectations
  • Focus on continuous improvement

Request Free!